Avid Bioservices Inc (CDMO)

[biopharm]

R&D business of what? Does that include beta bodies and Peregrine said sale or licensing ..etc and combine all this with recent events we have something brewing...

What would give better long-term potential for current shareholders and those up till Nov 27 ?

Lots of questions and if I read the complete PR by Peregrine again, there seems to be a requirement for the hiring of another firm that deals with M/A activity...quite big ones in the past so we wait : )